Highest-materiality recent filing
AI Financial receives Nasdaq delisting notice for bid price below $1.00
Notified July 1, 2026 of non-compliance with Nasdaq minimum $1.00 bid price rule.
AiFi says $180M WLFI tokens available; resolves going concern doubt
Holds ~6.9B WLFI tokens valued at ~$380M at $0.055/token as of June 9, 2026.
ALT5 Sigma acquires Block Street Corp. and Dectec; issues stock and pre-funded warrants
Acquired Block Street for 12,670,257 common shares valued at $12M plus $15M and $16M pre-funded warrants with performance milestones.
ALT5 Sigma names Tony Isaac permanent CEO with $600k salary, 5M share grant
Tony Isaac's title changed from Acting CEO to CEO; Employment Agreement approved April 20, 2026.
ALT5 Sigma regains full Nasdaq compliance; all three listing deficiencies cured
Filed Q3 10-Q on Jan 12, 2026; Nasdaq confirmed compliance with Listing Rule 5250(c)(1) on Jan 13.
ALT5 Sigma reports NAV $6.67/share, stock trades at $1.52 (77% discount); compliance restored
Estimated NAV of $843M ($6.67/share) vs. market cap ~$192M; shares trade at 77% discount.
ALT5 Sigma subsidiary secures $15M loan from World Liberty Financial, collateralized by WLFI tokens
$15M loan at 4.50% per annum, 24-month maturity; drawn fully on Jan 29, net proceeds ~$14.2M after prepaid interest and fees.
ALT5 Sigma appoints Steven M. Plumb as CFO with base salary of $339,400
Steven M. Plumb appointed CFO effective Nov 24, 2025; employment agreement finalized Jan 21, 2026.
CEO Peter Tassiopoulos to depart ALT5 Sigma on Dec 15, 2025; Acting CEO Tony Isaac named
Mutual separation agreement with CEO Peter Tassiopoulos; effective Dec 15, 2025.
Director David Danziger resigned Nov 25, 2025, causing audit committee to lack three independent members required by Nasdaq Rule 5605.
Alt5 Sigma appoints Tony Isaac acting CEO, Steven Plumb CFO; Hugh and Pitters exit
CFO/acting CEO Jonathan Hugh departed Nov 21, 2025 without cause; COO Ron Pitters given notice Nov 25, 2025.
ALT5 Sigma delays Q3 2025 10-Q filing citing incomplete review
Company will not file its September 27, 2025 quarterly report timely due to incomplete financial review.
ALT5 Sigma sues former consultant for data breach that may materially affect company
ALT5 Sigma filed lawsuit on Nov 4, 2025 in Delaware Chancery Court against Wellington Peel LLC, Jean-Francois Amyot, Hugues Benoit, and Prime Delta Corp.
Alt5 Sigma suspends CEO Peter Tassiopoulos; Jonathan Hugh named Acting CEO
Peter Tassiopoulos suspended as CEO effective Oct 16, 2025; removed of duties with pay.
ALT5 Sigma cancels Alyea spin-off as previously planned; evaluating other strategic options
The spin-off of Alyea Therapeutics will not occur with the June 2, 2025 record date as previously disclosed.
ALT5 Sigma reports $WLFI holdings of 7.28B tokens valued at $1.3B
ALT5 holds 7,283,585,650 $WLFI tokens; market value ~$1.31B at $0.18 per token.
May 7, 2025 Rwanda court found ALT5 Sigma Canada and former principal Andre Beauchesne guilty of illicit enrichment; confiscated ~$3.5M; appeal filed June 6.
ALT5 Sigma closes $1.5B offering led by World Liberty Financial; Eric Trump joins board
Closed $1.5B offering: $750M cash from 100M shares at $7.50 plus $750M in $WLFI tokens; to hold ~7.5% of total $WLFI supply.
Registered direct offering of 100M shares at $7.50 for ~$750M gross; private placement receives $750M in $WLFI tokens for 1M shares + 99M pre-funded warrants.
ALT5 Sigma acquires Mswipe crypto-enabled payment card business
ALT5 acquired Mswipe, a multi-currency fiat/crypto payment card platform operating on Visa/Mastercard networks.
ALT5 Sigma sets June 2 record date for Alyea separation; names prospective leadership
Record date of June 2, 2025 for Alyea separation; method (spin-off/split-off) to be announced later.
ALT5 Sigma sets June 2 record date for Alyea Therapeutics separation
Record date of June 2, 2025, for transaction to separate healthcare segment (Alyea Therapeutics).
ALT5 Sigma posts record Q1 fintech rev $5.51M, Adj EBITDA $1.15M; acquires Mswipe
Fintech revenue of $5.51M for Q1 2025, a record quarter.
ALT5 Sigma Q4 fintech revenue $5.4M; 1,000+ customers; appoints COO
Q4 fintech revenue $5.42M; full-year fintech revenue (from May 15) $12.53M; adjusted EBITDA ~$1.03M.
ALT5 Sigma to spin off healthcare assets into Alyea; LOI to acquire Soin Bioscience pain patch tech
All director nominees re-elected; CEO Peter Tassiopoulos elected to board for first time.
ALT5 Sigma reports record Q3 fintech revenue of $4.94M; net income $714K
Q3 fintech revenue $4.94M, gross profit $2.39M (~48% margin), net income $714K.
Sold three units: one $1.784M debenture + 400,000-share warrant; two $404,454.39 debentures each + 90,909-share warrants.
JanOne acquisition target Alt 5 Sigma reports 2023 net profit but auditor flags going concern
Alt 5 Sigma 2023 net profit $3.36M, revenue $11.97M (up 31% YoY); diluted EPS $0.13.
JanOne regains Nasdaq compliance on stockholders' equity as of June 4, 2024
Nasdaq letter confirms compliance with Listing Rule 5550(b)(1) based on $3.773M equity in March 31, 2024 10-Q.
JanOne settles SEC civil action; consents to $250K penalty and permanent injunction
Settlement with SEC resolves August 2021 complaint for alleged violation of Section 10(b) and Rule 10b-5.
JanOne acquires Alt 5 Sigma for ~$16M in equity; Alt 5 becomes wholly-owned subsidiary
Consideration: ~1.8M JanOne common shares (19.9% of outstanding) valued at $4.14/share, plus 34,207 Series B Preferred shares ($250 liquidation preference each).
Tony Isaac will step down as our Chief Executive Officer effective as of the Start Date. Tony will continue to serve as our President and will continue to serve as our Chairman on the Board of Directors (our “Board”).
appointed Peter Tassiopoulos to serve as our Chief Executive Officer, effective September 16, 2024
Effective October 5, 2021, JanOne Inc. (the “Company”) and its Board of Directors appointed Tony Isaac, the Company’s current Chief Executive Officer, as the Company’s Corporate Secretary.
Max materiality 1.00 · Median 0.60 · Most common event other_material